As an expert in the treatment of Tourette Syndrome (TS), recently, Dr. Coffman was asked to author an article on the pharmacological treatment of Tourette Syndrome.

In collaboration with Dr. Quezada, the paper was published in CNS Drugs Journal, focusing on current approaches and new developments regarding treatment of Tourette Syndrome. The team developed a visual algorithm to help guide the treatment of TS using medication based on the level-of-evidence and side-effects. It has been designed for others to use both inside the U.S. and globally. In this podcast, Drs. Coffman and Quezada will discuss the findings of the review publication.

Neonatal pharmacotherapy is a field ripe with opportunity. Efficacy and toxicity is unpredictable and varies greatly for many drug classes commonly used. Weight-based dosing continues to be the standard of care as individualized drug markers are lacking. To better understand variability in drug response, the focus must shift from drug dosing to drug exposure.

Tamorah Lewis, MD, neonatologist and clinical pharmacologist, joins us to discuss how pharmacotherapy and individualized medicine can transform care for critically ill newborns.

Approximately 10 to 15 percent of childhood cancer cases are due to a genetic predisposition. Children’s Mercy Kansas City is searching within the genetic code to not only identify genes that may lead to cancer, but to find answers in how to better treat or cure pediatric cancer.

Erin Guest, MD, Director of Cancer Genomics at Children’s Mercy, discusses the growing role of cancer genomics and how big data, new tests, and personalized treatments could change the future of pediatric cancer treatment.

Thanks to the research being done in CKid, we know that children diagnosed with chronic kidney disease progress over time to dialysis and transplantation. That makes it very important to address therapies which can mitigate the progression of chronic kidney disease.

Joining the show today is Tarak Srivastava, MD, he has been awarded R01 funding from the National Institutes of Health to work on targeting EP2, one of the four PGE2 receptors to mitigate hyperfiltration–mediated kidney injury as a way to delay the progression of chronic kidney disease in children born with congenital anomalies of kidney and urinary tract (CAKUT).

Obstructive sleep apnea is a common but serious condition that inhibits healthy, restful sleep and may lead to learning, behavior and physical health issues in children. Zarmina Ehsan, MD discusses obstructive sleep apnea in infants and children, why it’s necessary to conduct a sleep study to diagnose the condition and how to treat and manage the condition.

In pediatrics care most often supports life-sustaining treatment to promote the best interests of the child. But in some circumstances (after weighing the balance of benefits and burdens of a range of treatment choices) continuing life-sustaining treatment is decided to no longer be in the child’s best interests. Collaboration and clear communication are essential in these difficult discussions.

Join Bioethicist and Neonatologist Brian Carter, MD at Children’s Mercy Kansas City, as he provides insights on his recommendations and contributions to the American Academy of Pediatrics’ newly updated policy statement on how to promote the best possible end-of-life care for children.

It’s well-accepted that there are a variety of complex pathways that contribute to abdominal pain in children; but what are these pathways, and how can they be measured? By combining the data from mobile body sensors and self-reporting from participants, researchers at Children’s Mercy Kansas City were able apply “big data” to identify pain triggers for each individual patient. The results were very encouraging.

Join Dr. Jennifer Schurman with the Division of Gastroenterology at Children’s Mercy Kansas City as she introduces us to the importance of monitoring and collecting data on triggers for abdominal pain and the value that data holds for individualizing pain treatment in the clinic setting, real-time.

Did you know over 17,000 children are treated for lawnmower injuries each year in the US, resulting in 4,000 trips to the ER. About 75 children die annually from these injuries.

Our Guest Dale Jarka, MD is leading a first of its kind research study at Children’s Mercy to better define the causes, patterns and effects of Lawn Mower injuries, identify predictors of severe injuries in order to elevate public education and prevent injuries.

Manometry has long been the standard to measure colorectal activity, but it’s a lengthy and invasive test.

Doctors at Children’s Mercy Kansas City wanted to know if there was a better, non-invasive way to monitor colonic activity. The search for an answer led to a promising innovation. Along with a scientific partner, John Rosen, MD, developed a device that monitors colorectal activity using electrical bio-impedance with electrodes on the skin.

Join Dr. John Rosen with the Division of Gastroenterology at Children’s Mercy Kansas City, as he introduces us to colonic monitoring, his pre-clinical findings presented at a major gastroenterology conference in 2017, and the potential the new device holds to make colorectal activity detection more accessible to patients.

What are the risk factors for CKID progression? Should children with CKID be screened for cardiovascular risks? Can we predict relative time to a composite event?

These are a few of the questions being answered by the CKID study. To date, the translational research study has resulted in more than 90 publications.

Listen as Dr. Warady highlights some of the key findings that are shaping care and providing answers that matter now to pediatric patients with CKID.